Kate Haviland, CEO: Blueprint Medicines BPMC Sell · Filed 25/04/03

Trade details

Type: Insider sale
Amount: $8,859
Shares · price: 100 sh · $88.59 a share
Held after: 165,929 sh
Stock: Blueprint Medicines BPMC
Person: Kate HavilandCEO
Trade date: 25/04/01
Filed: 25/04/03
Days to filing: 2 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

Blueprint Medicines trades, last 26 weeks

What else happened in Blueprint Medicines around then

Filed or reported within 30 days of the trade day · 25/03/02~25/05/01

Kate Haviland's recent trades

Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$104.8K
1,200 sh
$104.8K
Filed 25/04/03
Traded 25/04/01
Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$51.5K
598 sh
$51.5K
Filed 25/04/03
Traded 25/04/01
Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$51.3K
600 sh
$51.3K
Filed 25/04/03
Traded 25/04/01
Kate HavilandCEO
SellBlueprint Medicines
Sell
Blueprint Medicines
BPMC
$1.4M
16,151 sh
$1.4M
Filed 25/03/07
Traded 25/03/05
Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$159.4K
1,446 sh
$159.4K
Filed 25/01/23
Traded 25/01/21